SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-049942
Filing Date
2022-04-26
Accepted
2022-04-26 07:01:33
Documents
3
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223422-1_def14a.htm DEF 14A 1039103
2 GRAPHIC tm223422d1-pc_proxy01bw.jpg GRAPHIC 166854
3 GRAPHIC tm223422d1-pc_proxy024c.jpg GRAPHIC 182580
  Complete submission text file 0001104659-22-049942.txt   1521269
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 22851720
SIC: 2835 In Vitro & In Vivo Diagnostic Substances